PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.
Related products
Wegovy 0.25mg/0.5ml Inj. x 1Pen
Semaglutide Injection
Xeloda 500mg x 120Caps (NAFDAC)
Capecitabine
Wegovy 0.5mg/0.5ml Inj. x 1Pen
Semaglutide Injection


















